These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2865415)

  • 21. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    Toll L; Berzetei-Gurske IP; Polgar WE; Brandt SR; Adapa ID; Rodriguez L; Schwartz RW; Haggart D; O'Brien A; White A; Kennedy JM; Craymer K; Farrington L; Auh JS
    NIDA Res Monogr; 1998 Mar; 178():440-66. PubMed ID: 9686407
    [No Abstract]   [Full Text] [Related]  

  • 24. [Opiate receptors, endorphins and their antagonists].
    Papin AA; Karelin AA
    Anesteziol Reanimatol; 1984; (3):52-61. PubMed ID: 6148029
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonists.
    Katz R; Osborne S; Ionescu F; Andrulis P; Bates R; Beavers W; Chou PC; Loew G; Berkowitz D
    NIDA Res Monogr; 1978; (22):441-63. PubMed ID: 30912
    [No Abstract]   [Full Text] [Related]  

  • 28. 7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.
    Ohkawa S; Portoghese PS
    J Med Chem; 1998 Oct; 41(21):4177-80. PubMed ID: 9767654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
    Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
    Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reversible binding of naloxazine and 14-hydroxydihydromorphazine with opiate receptors].
    Li LY; Ye CY; Zhang PW; Tian M; Jin YC
    Yao Xue Xue Bao; 1984 Apr; 19(4):251-5. PubMed ID: 6093431
    [No Abstract]   [Full Text] [Related]  

  • 33. Alpha 2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals.
    Demehri S; Samini M; Namiranian K; Rastegar H; Mehr SE; Homayoun H; Roushanzamir F; Jorjani M; Dehpour AR
    Auton Autacoid Pharmacol; 2003 Aug; 23(4):201-7. PubMed ID: 15084186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid pharmacology.
    Trescot AM; Datta S; Lee M; Hansen H
    Pain Physician; 2008 Mar; 11(2 Suppl):S133-53. PubMed ID: 18443637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E; Rónai AZ
    Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative relationship between antinociceptive activity and opiate receptor affinity: the importance of lipophilicity.
    Jacobson AE
    NIDA Res Monogr; 1978; (22):129-45. PubMed ID: 30906
    [No Abstract]   [Full Text] [Related]  

  • 38. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opiates and thermoregulation in mice. III. Agonist-antagonists.
    Rosow CE; Miller JM; Poulsen-Burke J; Cochin J
    J Pharmacol Exp Ther; 1982 Mar; 220(3):468-75. PubMed ID: 6121044
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of morphine on the release of excitatory amino acids in the rat hind instep: Pain is modulated by the interaction between the peripheral opioid and glutamate systems.
    Jin YH; Nishioka H; Wakabayashi K; Fujita T; Yonehara N
    Neuroscience; 2006; 138(4):1329-39. PubMed ID: 16473472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.